A multinational, multicenter, open-label, controlled, randomised, parallel group study to evaluate the efficacy and safety of EMD 121974 and gemcitabine or gemcitabine alone in patients with advanced, unresectable pancreatic cancer

2013 ◽  
Author(s):  
Helmut Friess
Sign in / Sign up

Export Citation Format

Share Document